(Q81265265)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647960%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Do subjective symptoms of obstructive voiding correlate with post-void residual urine volume in women? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647960%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Mesfer Al-Shahrani

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647960%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Danny Lovatsis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647960%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

29 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647960%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647960%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647960%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

12-4; discussion 14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647960%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group

7 January 2020

cites work

1 reference

12 December 2020

Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

1 reference

12 December 2020

Clinical predictors of urinary incontinence in women

1 reference

12 December 2020

Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group

1 reference

12 December 2020

Do urinary symptoms correlate with urodynamic findings?

1 reference

12 December 2020

Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology

1 reference

12 December 2020

Prevalence and characteristics of voiding difficulties in women: are subjective symptoms substantiated by objective urodynamic data?

1 reference

12 December 2020

The significance of the American Urological Association symptom index score in the evaluation of women with bladder outlet obstruction

1 reference

12 December 2020

Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire

1 reference

12 December 2020

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.

1 reference

12 December 2020

Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity

1 reference

12 December 2020

Bladder outlet obstruction in women: prevalence, recognition, and management.

1 reference

12 December 2020

Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial

1 reference

12 December 2020

10.1007/S00192-004-1202-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647960%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference